TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

RYVU

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

RYVU

ST13

US500000079280613

Classe

1, 5, 9, 42

Pedido

79280613

Registro

6279534

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

36

Atualização mais recente

03/03/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 9, 42

Data de depósito

11/12/2019

Data de registro

02/03/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

02/03/2021

Última transação

03/03/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

09

Localização do titular

PL

Examinador

BERNS, LEE ANNE

Unidade examinadora

M90

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Ryvu Therapeutics SA

Representantes

Claudia W. Stangle Leydig, Voit & Mayer, Ltd.

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 9Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemical preparations being additives for use in the manufacture of pharmaceuticals; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical products for biotechnological purposes, namely, chemicals for use in biotechnological research and product development; chemicals for use in the agrochemical industry

Classe 5

Chemico-pharmaceutical preparations, namely, chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer and for use in immunology and oncology; chemical preparations for pharmaceutical purposes for the treatment of cancer and for use in immunology and oncology; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cancer; biotechnological preparations for medical use in the nature of biological preparations for the treatment of cancer and for use immunology and oncology; medicines for human purposes, namely, medicines for the treatment of cancer and for use in immunology and oncology; adjuvants for medical purposes; biological tissue cultures for medical purposes; biological preparations being biological tissue cultures for veterinary purposes; biological preparations for medical purposes, namely, for treatment of cancer and for use in immunology and oncology; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; medical preparations, namely, for treatment of cancer and for use in oncology; diagnostic preparations and materials being diagnostic preparations for medical purposes; chemical preparations for medical purposes namely, for treatment of cancer and for use in immunology and oncology; immunomodulators being a type of pharmaceutical preparation for the treatment of cancer; immunostimulants; immunoassay reagents for medical use; chemotherapeutics; chemical reagents for medical or veterinary purposes; biological preparations for the treatment of cancer; mixed biological preparations for medical purposes, namely, for the treatment of cancer; pharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances, namely, for treatment of cancer and for use in immunology and oncology; anti-cancer preparations

Classe 9

Downloadable computer software for use with medical diagnosis, research, and treatment, namely, for analyzing medical data and diagnosing medical conditions, for evaluation of suggested medical treatment, analyzing and evaluating medical data for mitigation or prevention of disease, for processing data related to clinical trials, and for use with the development, production, and research of pharmaceuticals, namely, data processing, data analysis and data evaluation, processing and analyzing data related to clinical trials, evaluating and analyzing pharmaceutical ingredients and facilitating formulation and administration of pharmaceuticals

Classe 42

Research and development services in the field of immunology; chemistry services, namely, research in the field of immunology and oncology; chemical laboratories; chemistry consultation; testing of chemicals; chemical analysis; scientific research relating to chemistry; chemical research laboratory services; research and development services in the field of chemistry; provision of scientific information relating to the chemical industry; preparation of reports relating to chemical research; research and development in the pharmaceutical and biotechnology fields; laboratory research services relating to pharmaceuticals; information technology consultancy services for the pharmaceutical and healthcare industries; scientific research; computer aided scientific research services; biochemical research and analysis; genetic research; clinical research in the field of immunology and oncology; biological research; biological analysis; scientific research relating to biology; custom development of biological samples for research purposes; medical research; research to develop new products; research in the field of gene therapy; research and development in the field of diagnostic preparations; information on the subject of scientific research in the field of biochemistry and biotechnology; consultancy relating to pharmaceutical research; scientific research for medical purposes in the area of cancerous diseases; pharmaceutical products development; pharmaceutical product evaluation; testing of pharmaceuticals; conducting clinical trials for others for pharmaceutical products; research on the subject of pharmaceuticals; scientific laboratory services; scientific research services relating to the isolation and cultivation of human tissues and cells; computer aided scientific testing in the field of immunology and oncology; scientific and technological design, namely, design in the fields of biochemistry and biotechnology, namely, custom design of pharmaceuticals, chemicals, biological preparations, scientific software, pharmaceutical software, medical software, medical instruments and devices; software design and development; design and development of medical technology, namely, technology research in the field of medical instruments and devices; design and development of software for database management; pharmaceutical research and development; providing scientific information about the results of clinical trials for pharmaceutical products; technological research, namely, research in the field of pharmaceuticals; engineering services relating to computers, namely, computer-aided engineering services for the biotechnology industry; computer systems analysis

Publicações

Histórico de despachos e eventos da marca no USPTO.

36 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

02/03/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

20/06/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/06/2021

FIMP

FINAL DISPOSITION PROCESSED

02/06/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/06/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

02/03/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

15/12/2020

PUBO

PUBLISHED FOR OPPOSITION

15/12/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

25/11/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/11/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

11/11/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

11/11/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

11/11/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

11/11/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

21/10/2020

ALIE

ASSIGNED TO LIE

20/10/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

20/10/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

20/10/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

20/10/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/10/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/10/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/10/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

06/10/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/10/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/10/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/10/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

06/10/2020

RFNT

REFUSAL PROCESSED BY IB

24/04/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

08/04/2020

RFRR

REFUSAL PROCESSED BY MPU

08/04/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

20/03/2020

CNRT

NON-FINAL ACTION WRITTEN

19/03/2020

MAFR

APPLICATION FILING RECEIPT MAILED

17/03/2020

DOCK

ASSIGNED TO EXAMINER

13/03/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

13/03/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/03/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace RYVU ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.